Citigroup’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,000
Closed -$43K 5668
2020
Q4
$43K Hold
10,000
﹤0.01% 4204
2020
Q3
$41K Buy
+10,000
New +$41K ﹤0.01% 3591
2020
Q2
Sell
-7,091
Closed -$20K 5219
2020
Q1
$20K Sell
7,091
-15,188
-68% -$42.8K ﹤0.01% 4377
2019
Q4
$84K Buy
22,279
+3,938
+21% +$14.8K ﹤0.01% 3650
2019
Q3
$94K Sell
18,341
-192
-1% -$984 ﹤0.01% 3481
2019
Q2
$115K Buy
18,533
+841
+5% +$5.22K ﹤0.01% 3542
2019
Q1
$126K Sell
17,692
-155,487
-90% -$1.11M ﹤0.01% 3432
2018
Q4
$1.48M Buy
173,179
+72,701
+72% +$621K ﹤0.01% 1737
2018
Q3
$2.01M Buy
100,478
+33,366
+50% +$668K ﹤0.01% 1510
2018
Q2
$1.73M Sell
67,112
-28,190
-30% -$728K ﹤0.01% 1549
2018
Q1
$2.28M Sell
95,302
-45,347
-32% -$1.08M ﹤0.01% 1383
2017
Q4
$4.77M Buy
140,649
+120,200
+588% +$4.07M ﹤0.01% 998
2017
Q3
$433K Buy
20,449
+20,351
+20,766% +$431K ﹤0.01% 2517
2017
Q2
$2K Buy
98
+97
+9,700% +$1.98K ﹤0.01% 4614
2017
Q1
$0 Buy
+1
New ﹤0.01% 4956
2016
Q4
Sell
-299
Closed -$5K 5007
2016
Q3
$5K Sell
299
-3,256
-92% -$54.4K ﹤0.01% 4667
2016
Q2
$54K Sell
3,555
-10,596
-75% -$161K ﹤0.01% 3662
2016
Q1
$204K Buy
14,151
+7,345
+108% +$106K ﹤0.01% 3463
2015
Q4
$193K Buy
6,806
+6,066
+820% +$172K ﹤0.01% 3088
2015
Q3
$12K Sell
740
-4,451
-86% -$72.2K ﹤0.01% 4317
2015
Q2
$136K Buy
5,191
+3,402
+190% +$89.1K ﹤0.01% 3035
2015
Q1
$31K Buy
1,789
+298
+20% +$5.16K ﹤0.01% 4145
2014
Q4
$26K Buy
1,491
+1,387
+1,334% +$24.2K ﹤0.01% 4476
2014
Q3
$2K Buy
104
+40
+63% +$769 ﹤0.01% 5182
2014
Q2
$1K Buy
+64
New +$1K ﹤0.01% 5353